CA1076752A - Arteries for use in heterologous transplants - Google Patents
Arteries for use in heterologous transplantsInfo
- Publication number
- CA1076752A CA1076752A CA239,283A CA239283A CA1076752A CA 1076752 A CA1076752 A CA 1076752A CA 239283 A CA239283 A CA 239283A CA 1076752 A CA1076752 A CA 1076752A
- Authority
- CA
- Canada
- Prior art keywords
- artery
- arteries
- tube
- solution
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000001367 artery Anatomy 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 claims abstract description 30
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 102000008186 Collagen Human genes 0.000 claims abstract description 9
- 108010035532 Collagen Proteins 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 9
- 229920001436 collagen Polymers 0.000 claims abstract description 9
- 210000001519 tissue Anatomy 0.000 claims abstract description 7
- 108091005804 Peptidases Proteins 0.000 claims abstract description 6
- 102000035195 Peptidases Human genes 0.000 claims abstract description 6
- 238000004132 cross linking Methods 0.000 claims abstract description 6
- 230000002797 proteolythic effect Effects 0.000 claims abstract description 6
- 210000003205 muscle Anatomy 0.000 claims abstract description 5
- 239000004365 Protease Substances 0.000 claims description 11
- 108090000270 Ficain Proteins 0.000 claims description 9
- 235000019836 ficin Nutrition 0.000 claims description 9
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical group FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 9
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920002085 Dialdehyde starch Polymers 0.000 claims description 4
- 210000001715 carotid artery Anatomy 0.000 claims description 4
- 229940015043 glyoxal Drugs 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 abstract description 4
- 238000011109 contamination Methods 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 244000309466 calf Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 3
- 229960002218 sodium chlorite Drugs 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OFNXOACBUMGOPC-HZYVHMACSA-N 5'-hydroxystreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](CO)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O OFNXOACBUMGOPC-HZYVHMACSA-N 0.000 description 1
- 239000004429 Calibre Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 108010081750 Reticulin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- -1 for example Proteins 0.000 description 1
- OFNXOACBUMGOPC-UHFFFAOYSA-N hydroxystreptomycin Natural products CNC1C(O)C(O)C(CO)OC1OC1C(C=O)(O)C(CO)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O OFNXOACBUMGOPC-UHFFFAOYSA-N 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- OKPOKMCPHKVCPP-UHFFFAOYSA-N isoorientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(OC)=C(O)C=C3CCN2C)=C1 OKPOKMCPHKVCPP-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- JTQHYPFKHZLTSH-UHFFFAOYSA-N reticulin Natural products COC1CC(OC2C(CO)OC(OC3C(O)CC(OC4C(C)OC(CC4OC)OC5CCC6(C)C7CCC8(C)C(CCC8(O)C7CC=C6C5)C(C)O)OC3C)C(O)C2OC)OC(C)C1O JTQHYPFKHZLTSH-UHFFFAOYSA-N 0.000 description 1
- 239000008237 rinsing water Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/062—Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/915—Method or apparatus for preparing biological material
- Y10S623/916—Blood vessel
- Y10S623/917—Collagen
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19742453363 DE2453363B2 (de) | 1974-11-11 | 1974-11-11 | Verfahren zur herstellung heterologer arterientransplantate |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1076752A true CA1076752A (en) | 1980-05-06 |
Family
ID=5930516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA239,283A Expired CA1076752A (en) | 1974-11-11 | 1975-11-10 | Arteries for use in heterologous transplants |
Country Status (26)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1982000091A1 (en) * | 1980-07-01 | 1982-01-21 | V Ketharanathan | Vascular prostheses |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5230097A (en) * | 1975-09-02 | 1977-03-07 | Kaneyasu Miyata | Method of mounting different substitute blood vessel |
JPS5675152A (en) * | 1979-11-26 | 1981-06-22 | Matsuda Ika Kogyo | Reinforcing material for medical treatment |
ATE9867T1 (de) * | 1980-03-31 | 1984-11-15 | Solco Basel Ag | Verfahren zur herstellung neuer organtransplantate. |
US4911713A (en) * | 1986-03-26 | 1990-03-27 | Sauvage Lester R | Method of making vascular prosthesis by perfusion |
CH671683A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1987-03-05 | 1989-09-29 | Sulzer Ag | |
CH675679A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1987-12-07 | 1990-10-31 | Sulzer Ag | |
US5078735A (en) * | 1990-06-18 | 1992-01-07 | Mobin Uddin Kazi | Prosthetic grafting method for bypass surgery |
US5120833A (en) * | 1991-03-15 | 1992-06-09 | Alexander Kaplan | Method of producing grafts |
US5437287A (en) * | 1992-08-17 | 1995-08-01 | Carbomedics, Inc. | Sterilization of tissue implants using iodine |
JPH09510108A (ja) * | 1994-03-14 | 1997-10-14 | クリオライフ,インコーポレイティド | 移植用処理組織及び調製方法 |
US5595571A (en) * | 1994-04-18 | 1997-01-21 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
EP0757564A1 (en) * | 1994-04-29 | 1997-02-12 | Gore Hybrid Technologies, Inc. | Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same |
WO2000013612A1 (fr) * | 1998-09-07 | 2000-03-16 | Tapic International Co., Ltd. | Vaisseau sanguin artificiel |
US6432712B1 (en) * | 1999-11-22 | 2002-08-13 | Bioscience Consultants, Llc | Transplantable recellularized and reendothelialized vascular tissue graft |
EP1693025A1 (en) | 2005-02-17 | 2006-08-23 | Universität Zürich | Method of manufacturing a tissue-engineered prosthesis |
CN1903144A (zh) | 2005-07-29 | 2007-01-31 | 广东冠昊生物科技有限公司 | 生物型人工韧带及其制备方法 |
CN1903143A (zh) * | 2005-07-29 | 2007-01-31 | 广东冠昊生物科技有限公司 | 生物型人工血管及其制备方法 |
CN100482178C (zh) | 2005-08-04 | 2009-04-29 | 广东冠昊生物科技有限公司 | 带生物膜的血管瘤夹 |
EP2965769B1 (en) * | 2005-08-26 | 2018-12-26 | Regents of the University of Minnesota | Decellularization and recellularization of organs and tissues |
CN1986007B (zh) * | 2005-12-20 | 2011-09-14 | 广东冠昊生物科技股份有限公司 | 生物型外科补片 |
CN1986006A (zh) | 2005-12-20 | 2007-06-27 | 广州知光生物科技有限公司 | 生物型神经导管 |
CN1986001B (zh) * | 2005-12-20 | 2011-09-14 | 广东冠昊生物科技股份有限公司 | 生物护创膜 |
US20100023129A1 (en) * | 2008-07-22 | 2010-01-28 | Guo-Feng Xu | Jawbone prosthesis and method of manufacture |
CN101332316B (zh) * | 2008-07-22 | 2012-12-26 | 广东冠昊生物科技股份有限公司 | 生物型鼻梁植入体 |
CN101332314B (zh) * | 2008-07-22 | 2012-11-14 | 广东冠昊生物科技股份有限公司 | 生物型关节软骨修补件 |
WO2012031162A1 (en) | 2010-09-01 | 2012-03-08 | Doris Taylor | Methods of recellularizing a tissue or organ for improved transplantability |
US9290738B2 (en) | 2012-06-13 | 2016-03-22 | Miromatrix Medical Inc. | Methods of decellularizing bone |
WO2014015274A1 (en) | 2012-07-20 | 2014-01-23 | The General Hospital Corporation | Methods for tissue passivation |
WO2015009992A1 (en) | 2013-07-18 | 2015-01-22 | The General Hospital Corporation | Vessel treatment systems, methods, and kits |
WO2014151739A1 (en) | 2013-03-15 | 2014-09-25 | Miromatrix Medical Inc. | Use of perfusion decellularized liver for islet cell recellularization |
EP3509651B1 (en) | 2016-09-06 | 2022-12-28 | Miromatrix Medical Inc. | Use of resected liver serum for whole liver engineering |
US12263275B2 (en) | 2018-06-13 | 2025-04-01 | Miromatrix Medical Inc. | Fistula filler and deployment system |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1628966A (en) * | 1919-09-16 | 1927-05-17 | Glasel Charles John | Tanning apparatus |
US1724954A (en) * | 1921-05-20 | 1929-08-20 | United Shoe Machinery Corp | Method for treating hides and skins |
US2900644A (en) * | 1955-11-01 | 1959-08-25 | Johnson & Johnson | Heterograft material |
US3093439A (en) * | 1961-07-05 | 1963-06-11 | Johnson & Johnson | Process for preparing tanned collagenous material with dialdehyde starch |
US3093440A (en) * | 1961-07-05 | 1963-06-11 | Johnson & Johnson | Process for preparing collagenous material tanned with polyacrolein |
US3966401A (en) * | 1974-07-01 | 1976-06-29 | Hancock Laboratories Incorporated | Preparing natural tissue for implantation so as to provide improved flexibility |
-
1974
- 1974-11-11 DE DE19742453363 patent/DE2453363B2/de active Granted
-
1975
- 1975-01-01 AR AR261129A patent/AR207877A1/es active
- 1975-10-13 NL NL7512007A patent/NL7512007A/xx not_active Application Discontinuation
- 1975-10-30 FI FI753040A patent/FI753040A7/fi not_active Application Discontinuation
- 1975-10-30 PH PH17723A patent/PH11934A/en unknown
- 1975-10-31 YU YU02763/75A patent/YU276375A/xx unknown
- 1975-10-31 GB GB45405/75A patent/GB1488534A/en not_active Expired
- 1975-10-31 IL IL48395A patent/IL48395A/xx unknown
- 1975-11-05 ES ES442354A patent/ES442354A1/es not_active Expired
- 1975-11-05 IT IT52088/75A patent/IT1052161B/it active
- 1975-11-05 BE BE161624A patent/BE835292A/xx unknown
- 1975-11-07 AT AT849875A patent/AT346469B/de not_active IP Right Cessation
- 1975-11-07 PL PL1975184572A patent/PL102824B1/pl unknown
- 1975-11-07 DD DD189335A patent/DD121710A5/xx unknown
- 1975-11-07 JP JP13315475A patent/JPS5516016B2/ja not_active Expired
- 1975-11-07 US US05/629,752 patent/US4083066A/en not_active Expired - Lifetime
- 1975-11-10 CA CA239,283A patent/CA1076752A/en not_active Expired
- 1975-11-10 SE SE7512608A patent/SE7512608L/xx not_active Application Discontinuation
- 1975-11-10 DK DK504575A patent/DK142044C/da not_active IP Right Cessation
- 1975-11-10 EG EG660/75A patent/EG12503A/xx active
- 1975-11-10 FR FR7534344A patent/FR2290182A1/fr active Granted
- 1975-11-10 BR BR7507404*A patent/BR7507404A/pt unknown
- 1975-11-10 ZA ZA757039A patent/ZA757039B/xx unknown
- 1975-11-11 HU HU75SO00001158A patent/HU172194B/hu unknown
- 1975-11-11 CS CS757594A patent/CS193058B2/cs unknown
- 1975-11-11 CH CH1457775A patent/CH595105A5/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1982000091A1 (en) * | 1980-07-01 | 1982-01-21 | V Ketharanathan | Vascular prostheses |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1076752A (en) | Arteries for use in heterologous transplants | |
CA2312376C (en) | Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials | |
EP0052288B1 (de) | Kollagenpräparate, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin | |
US4798611A (en) | Enhancement of xenogeneic tissue | |
DE3918628C2 (de) | Verfahren zur Herstellung eines vernetzten Biopolymers auf der Grundlage von Kollagen, Implantat aus diesem Biopolymeren und Verfahren zur Herstellung dieses Implantats | |
US4456589A (en) | Preparation of animal tissues for surgical implantation in human recipients | |
US5413798A (en) | Process for preparing bovine pericard materials and use thereof | |
CN101626682A (zh) | 用于外科植入的生物组织 | |
JPH10507102A (ja) | 石灰化を軽減するための移植可能な生物学的組織の処理方法およびこのような方法で処理された生体補綴物 | |
JPH069606B2 (ja) | コラーゲン膜の製造方法 | |
JPH09502379A (ja) | 天然組織の改良された架橋 | |
Henry et al. | Specimen preparation for silicone plastination | |
Simionescu et al. | Lysine‐enhanced glutaraldehyde crosslinking of collagenous biomaterials | |
US20240299624A1 (en) | Prosthetic Tissue Treatment For Desirable Mechanical Properties | |
CN109833118A (zh) | 一种采用交联处理提高生物瓣膜稳定性的方法 | |
US2817437A (en) | Sterilization of collagenous sutures with epoxides | |
Hufnagel | Experimental and clinical observations on the transplantation of blood vessels | |
CN112674908A (zh) | 一种耐折弯的干燥生物心脏瓣膜及其制备方法 | |
RU1570058C (ru) | Способ получения сосудистых биопротезов | |
SU1537245A1 (ru) | Способ изготовлени сосудистых биопротезов | |
US4403041A (en) | Diagnosis of atherosclerosis | |
RU2228030C2 (ru) | Способ обработки биологических протезов сосудов | |
SU1107833A1 (ru) | Способ вы влени трупных п тен | |
SU1012856A1 (ru) | Способ консервации биологических тканей дл трансплантации | |
SU1407469A1 (ru) | Способ консервации трупной твердой мозговой оболочки |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |